menu search

2 reasons why pfizer might crush moderna in the mrna market. and 1 reason why moderna may stay ahead.

Pfizer's billion-dollar mRNA vaccine could be just the beginning....

February 17, 2022, 6:15 am

2 reasons why pfizer might crush moderna in the mrna market. and 1 reason why moderna may stay ahead.

Pfizer's billion-dollar mRNA vaccine could be just the beginning....

February 17, 2022, 6:15 am

2 reasons why pfizer might crush moderna in the mrna market. and 1 reason why moderna may stay ahead.

Pfizer's billion-dollar mRNA vaccine could be just the beginning....

February 17, 2022, 6:15 am

Pfizer (pfe) gets eu nod for somatrogon & pneumococcal jab

Pfizer (PFE) gets approval for pediatric growth hormone deficiency drug, Ngenla (somatrogon) and 20-valent pneumococcal conjugate v...

February 16, 2022, 1:09 pm

Pfizer (pfe) gets eu nod for somatrogon & pneumococcal jab

Pfizer (PFE) gets approval for pediatric growth hormone deficiency drug, Ngenla (somatrogon) and 20-valent pneumococcal conjugate v...

February 16, 2022, 1:09 pm

Pfizer (pfe) gets eu nod for somatrogon & pneumococcal jab

Pfizer (PFE) gets approval for pediatric growth hormone deficiency drug, Ngenla (somatrogon) and 20-valent pneumococcal conjugate v...

February 16, 2022, 1:09 pm

Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety

BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vac...

February 16, 2022, 9:48 am

Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety

BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vac...

February 16, 2022, 9:48 am

Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety

BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vac...

February 16, 2022, 9:48 am

Biontech unveils first modular mrna manufacturing facility in africa

BioNTech SE (NASDAQ: BNTX), which developed the first widely approved COVID-19 shot together with Pfizer Inc (NYSE: PFE), unveiled plans to establ...

February 16, 2022, 9:29 am

Biontech unveils first modular mrna manufacturing facility in africa

BioNTech SE (NASDAQ: BNTX), which developed the first widely approved COVID-19 shot together with Pfizer Inc (NYSE: PFE), unveiled plans to establ...

February 16, 2022, 9:29 am

Biontech unveils first modular mrna manufacturing facility in africa

BioNTech SE (NASDAQ: BNTX), which developed the first widely approved COVID-19 shot together with Pfizer Inc (NYSE: PFE), unveiled plans to establ...

February 16, 2022, 9:29 am

Biontech coo outlines plan to scale mrna vaccine production in africa

BioNTech Chief Operating Officer Sierk Poetting discusses the vaccine maker's plans to ship mRNA v...

February 16, 2022, 7:05 am

Biontech coo outlines plan to scale mrna vaccine production in africa

BioNTech Chief Operating Officer Sierk Poetting discusses the vaccine maker's plans to ship mRNA v...

February 16, 2022, 7:05 am

Biontech coo outlines plan to scale mrna vaccine production in africa

BioNTech Chief Operating Officer Sierk Poetting discusses the vaccine maker's plans to ship mRNA v...

February 16, 2022, 7:05 am

Why it's time to buy moderna stock again

The tide has turned for this once high-flying vaccine stock....

February 16, 2022, 6:56 am

Why it's time to buy moderna stock again

The tide has turned for this once high-flying vaccine stock....

February 16, 2022, 6:56 am

Why it's time to buy moderna stock again

The tide has turned for this once high-flying vaccine stock....

February 16, 2022, 6:56 am

Biontech unveils plans to develop mrna vaccine facilities in africa

BioNTech SE BNTX, +5.77% said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote sc...

February 16, 2022, 6:19 am

Biontech unveils plans to develop mrna vaccine facilities in africa

BioNTech SE BNTX, +5.77% said Wednesday it is developing turkey mRNA manufacturing facilities based on a container solution in an effort to promote sc...

February 16, 2022, 6:19 am


Search within

Pages Search Results: